The conclusions of Schleiden and Schwann are considered to represent the official formulation of 'cell theory' and their names are almost as closely linked to cell theory as are those of Watson ...

Gilead has cemented the role of its TROP2 drug Trodelvy in triple-negative breast cancer with a study win in combination with MSD's Keytruda.